Strong Prognostic Value of Microsatellite Instability in Intestinal Type Non-cardia Gastric Cancer

Annals of Surgical Oncology

Volumn 23, Issue 3, 2016, Pages 943-950

  Marrelli, Daniele ^a   Polom, Karol ^a   Pascale, Valeria ^a   Vindigni, Carla ^b   Piagnerelli, Riccardo ^a   De Franco, Lorenzo ^a   Ferrara, Francesco ^a   Roviello, Giandomenico ^b   Garosi, Lorenzo ^a   Petrioli, Roberto ^b   Roviello, Franco ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY HOSPITAL OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; FEMALE; FOLLOW UP; GASTRECTOMY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LONG TERM SURVIVAL; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; PREDICTIVE VALUE; PROSPECTIVE STUDY; SEX DIFFERENCE; STOMACH CANCER; SURVIVAL RATE; TUMOR INVASION; ADENOCARCINOMA; CARCINOMA, PAPILLARY; CARCINOMA, SIGNET RING CELL; CARDIA; CASE CONTROL STUDY; COMPARATIVE STUDY; GENETICS; INTESTINAL NEOPLASMS; LYMPH NODE METASTASIS; METABOLISM; PATHOLOGY; PHENOTYPE; POLYMERASE CHAIN REACTION; PROGNOSIS; SECONDARY; STOMACH NEOPLASMS;

ADENOCARCINOMA; AGED; CARCINOMA, PAPILLARY; CARCINOMA, SIGNET RING CELL; CARDIA; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; HUMANS; INTESTINAL NEOPLASMS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MICROSATELLITE INSTABILITY; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PHENOTYPE; POLYMERASE CHAIN REACTION; PROGNOSIS; PROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 84957842852     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-015-4931-3     Document Type: Article

References (32)

1. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–86.
2. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand. 1965;64:31–49.
3. Marrelli D, Roviello F, de Manzoni G, et al. Different patterns of recurrence in gastric cancer depending on Lauren’s histological type: longitudinal study. World J Surg. 2002;26:1160–5.
4. Bass AJ, Thorsson V, Shmulevich I, et al. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513:202–9.
5. Sunakawa Y, Lenz HJ. Molecular classification of gastric adenocarcinoma: translating new insights from the cancer genome atlas research network. Curr Treat Opt Oncol. 2015;16:331.
6. Yamamoto H, Adachi Y, Taniguchi H, Kunimoto H, Nosho K, Suzuki H, Shinomura Y. Interrelationship between microsatellite instability and microRNA in gastrointestinal cancer. World J Gastroenterol. 2012;18:2745–55.
7. Heinimann K. Toward a molecular classification of colorectal cancer: the role of microsatellite instability status. Front Oncol. 2013;3:272.
8. Lee HS, Choi SI, Lee HK, Kim HS, Yang HK, Kang GH et al. Distinct clinical features and outcomes of gastric cancers with microsatellite instability. Mod Pathol. 2002;15:632–40.
9. Beghelli S, de Manzoni G, Barbi S, et al. Microsatellite instability in gastric cancer is associated with better prognosis in only stage II cancers. Surgery. 2006;139:347–56.
10. Corso G, Pedrazzani C, Marrelli D, Pascale V, Pinto E, Roviello F. Correlation of microsatellite instability at multiple loci with long‐term survival in advanced gastric carcinoma. Arch Surg. 2009;144:722–7.
11. Choi YY, Bae JM, An JY, et al. Is microsatellite instability a prognostic marker in gastric cancer? A systematic review with meta-analysis. J Surg Oncol. 2014;110:129–35.
12. Edge SB, Byrd DR, Compton CC, eds. AJCC cancer staging manual, 7th edn. New York: Springer; 2010. p. 103–15.
13. Marrelli D, Morgagni P, de Manzoni G, et al. Prognostic value of the 7th AJCC/UICC TNM classification of noncardia gastric cancer: analysis of a large series from specialized Western centers. Ann Surg. 2012;255:486–91.
14. Boland CR, Thibodeau SN, Hamilton SR, et al. A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 1998;58:5248–57.
15. dos Santos NR, Seruca R, Constancia M, Seixas M, Sobrinho-Simoes M. Microsatellite instability at multiple loci in gastric carcinoma: clinicopathologic implications and prognosis. Gastroenterology. 1996;110:38–44.
16. Marrelli D, Morgagni P, de Manzoni G, et al. Italian Research Group for Gastric Cancer. External validation of a score predictive of recurrence after radical surgery for non-cardia gastric cancer: results of a follow-up study. J Am Coll Surg. 2015;221:280–90.
17. Oki E, Kakeji Y, Zhao Y, et al. Chemosensitivity and survival in gastric cancer patients with microsatellite instability. Ann Surg Oncol. 2009;16:2510–15.
18. Seo HM, Chang YS, Joo SH, Kim YW, Park YK, Hong SW. Clinicopathologic characteristics and outcomes of gastric cancers with the MSI-H phenotype. J Surg Oncol. 2009;99:143–7.
19. Wu M, Semba S, Oue N, Ikehara N, Yasui W, Yokozaki H. BRAF/K-ras mutation, microsatellite instability, and promoter hypermethylation of hMLH1/MGMT in human gastric carcinomas. Gastric Cancer 2004;7:246–53.
20. Vauhkonen M, Vauhkonen H, Sajantila A, Sipponen P. Differences in genomic instability between intestinal- and diffuse-type gastric cancer. Gastric Cancer. 2005;8:238–44.
21. Roviello F, Pedrazzani C, Marrelli D, et al. Super-extended (D3) lymphadenectomy in advanced gastric cancer. Eur J Surg Oncol. 2010; 36:439-46.
22. Arai T, Sakurai U, Sawabe M, et al. Frequent microsatellite instability in papillary and solid-type, poorly differentiated adenocarcinomas of the stomach. Gastric Cancer. 2013;16:505–12.
23. Marrelli D, Połom K, de Manzoni G, Morgagni P, Baiocchi GL, Roviello F. Multimodal treatment of non-cardia gastric cancer in West: where are we going? World J Gastroenterol. 2015;21:7954–69.
24. Marrelli D, Pedrazzani C, Morgagni P, et al. Changing clinical and pathological features of gastric cancer over time. Br J Surg. 2011;98:1273–83.
25. Wu H, Rusiecki JA, Zhu K, Potter J, Devesa SS. Stomach carcinoma incidence patterns in the United States by histologic type and anatomic site. Cancer Epidemiol Biomarkers Prev. 2009;18:1945–52.
26. Roviello F, Marrelli D, Vindigni C, De Stefano A, Spina D, Pinto E. P53 accumulation is a prognostic factor in intestinal-type gastric carcinoma but not in the diffuse type. Ann Surg Oncol. 1999;6:739–45.
27. Yang M, Kim HS, Cho MY. Different methylation profiles between intestinal and diffuse sporadic gastric carcinogenesis. Clin Res Hepatol Gastroenterol 2014;38:613–20.
28. Lou L, Wang Y, Cui J, Yan X, Xue L, Li Y. Differential expression of Pim-3, c-Myc, and p-p27 proteins in adenocarcinomas of the gastric cardia and distal stomach. Tumour Biol. 2014;35:5029–36.
29. Henson DE, Dittus C, Younes M, Nguyen H, Albores-Saavedra J. Differential trends in the intestinal and diffuse types of gastric carcinoma in the United States, 1973–2000: increase in the signet ring cell type. Arch Pathol Lab Med. 2004;128:765–70.
30. Tan IB, Ivanova T, Lim KH, et al. Intrinsic subtypes of gastric cancer, based on gene expression pattern, predict survival and respond differently to chemotherapy. Gastroenterology 2011;141:476–85.
31. Taghavi S, Jayarajan SN, Davey A, Willis AI. Prognostic significance of signet ring gastric cancer. J Clin Oncol. 2012;30:3493–8.
32. An JY, Kim H, Cheong JH, Hyung WJ, Kim H, Noh SH. Microsatellite instability in sporadic gastric cancer: Its prognostic role and guidance for 5‐FU based chemotherapy after R0 resection. Int J Cancer. 2012;131:505–11.